Related references
Note: Only part of the references are listed.International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome
Dimana Dimitrova et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
The Emerging Treatment Options of Plasmablastic Lymphoma: Analysis of 173 Individual Patient Outcomes
Nafie F. Makady et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Bortezomib- and Lenalidomide-Based Treatment of Refractory Plasmablastic Lymphoma
Koji Ando et al.
ONCOLOGY RESEARCH AND TREATMENT (2020)
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma
Jorge J. Castillo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Bortezomib in combination with dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) induces long-term survival in patients with plasmablastic lymphoma: a retrospective analysis
Christopher Dittus et al.
LEUKEMIA & LYMPHOMA (2018)
Activated PI3 Kinase Delta Syndrome: From Genetics to Therapy
David Michalovich et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Treatment of Activated PI3Kδ Syndrome
Tanya I. Coulter et al.
FRONTIERS IN IMMUNOLOGY (2018)
Novel PIK3CD mutations affecting N-terminal residues of p110d cause activated PI3Kd syndrome (APDS) in humans
Andrew J. Takeda et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study
Tanya I. Coulter et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Activating PI3K mutations in a cohort of 669 patients with primary immunodeficiency
M. Elgizouli et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study
Elodie Elkaim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients
Sanam Loghavi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency
Waleed Al-Herz et al.
FRONTIERS IN IMMUNOLOGY (2014)